Abstract
In patients with stable COPD, is a short-acting beta agonist alone as effective for controlling symptoms as a SABA plus a short-acting muscarinic antagonist?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Evidence-based practice : patient-oriented evidence that matters
Paper Title
Journal
Date
